ADAP Stock Summary and Trading Ideas (Adaptimmune Therapeutics PLC - American Depositary Shares | NASDAQ:ADAP)

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.

Adaptimmune Therapeutics PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol ADAP.

As of April 19, 2024, ADAP stock price climbed to $0.98 with 1,404,244 million shares trading.

ADAP has a beta of 1.58, meaning it tends to be more sensitive to market movements. ADAP has a correlation of 0.04 to the broad based SPY ETF.

ADAP has a market cap of $249.54 million. This is considered a Small Cap stock.

Last quarter Adaptimmune Therapeutics PLC - American Depositary Shares reported $231,000 in Revenue and -$.24 earnings per share. This fell short of revenue expectation by $-20 million and missed earnings estimates by -$.14.

In the last 3 years, ADAP stock traded as high as $6.86 and as low as $.42.

The top ETF exchange traded funds that ADAP belongs to (by Net Assets): SPDW, GWX, APIE, FESM, INNO.

ADAP has underperformed the market in the last year with a price return of -35.3% while the SPY ETF gained +21.2%. However, in the short term, ADAP had mixed performance relative to the market. It has outperformed in the last 3 months, returning +39.0% vs +3.0% return in SPY. But in the last 2 weeks, ADAP shares have been beat by the market, returning -28.7% compared to an SPY return of -4.5%.

ADAP support price is $.85 and resistance is $.95 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADAP stock will trade within this expected range on the day.